Wai Chun Bio-Technology Limited (HKG:0660)
Hong Kong
· Delayed Price · Currency is HKD 0.231
-0.002 (-0.86%)
Mar 10, 2026, 2:01 PM HKT
Wai Chun Bio-Technology Income Statement
Financials in millions HKD. Fiscal year is July - June.
Millions HKD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Revenue | 568.26 | 377.17 | 370.07 | 773.65 | 671.46 | 495.38 | Upgrade
|
| Revenue Growth (YoY) | 66.75% | 1.92% | -52.17% | 15.22% | 35.55% | -12.72% | Upgrade
|
| Cost of Revenue | 517.73 | 341.16 | 335.89 | 723.24 | 611.33 | 457.8 | Upgrade
|
| Gross Profit | 50.53 | 36 | 34.18 | 50.41 | 60.12 | 37.58 | Upgrade
|
| Selling, General & Admin | 47.55 | 34.91 | 32.73 | 35.87 | 41.33 | 36.81 | Upgrade
|
| Other Operating Expenses | -2.53 | -1.29 | -1.87 | -0.32 | 0.15 | 0.23 | Upgrade
|
| Operating Expenses | 44.25 | 32.28 | 32.56 | 38.5 | 42.13 | 35.95 | Upgrade
|
| Operating Income | 6.28 | 3.73 | 1.62 | 11.92 | 17.99 | 1.62 | Upgrade
|
| Interest Expense | -8.32 | -13.65 | -17.91 | -17.11 | -13.97 | -12.82 | Upgrade
|
| Interest & Investment Income | 0.01 | 0.01 | 0.01 | 0.04 | 0.02 | - | Upgrade
|
| Other Non Operating Income (Expenses) | 2.92 | 2.92 | -3.13 | - | 2.66 | - | Upgrade
|
| EBT Excluding Unusual Items | 0.88 | -7 | -19.41 | -5.16 | 6.71 | -11.2 | Upgrade
|
| Gain (Loss) on Sale of Assets | -0.18 | -0.18 | -0.61 | - | 0.03 | - | Upgrade
|
| Asset Writedown | -1.75 | -1.75 | -58.15 | -0.54 | - | - | Upgrade
|
| Other Unusual Items | - | - | - | - | -4.22 | - | Upgrade
|
| Pretax Income | -1.05 | -8.93 | -78.17 | -5.7 | 2.52 | -11.2 | Upgrade
|
| Income Tax Expense | 2.34 | 1.77 | -12.46 | 4.36 | 3.44 | 1.45 | Upgrade
|
| Earnings From Continuing Operations | -3.39 | -10.7 | -65.71 | -10.06 | -0.93 | -12.65 | Upgrade
|
| Minority Interest in Earnings | -3.51 | -3.92 | 21.5 | -5.37 | -13.44 | -4.38 | Upgrade
|
| Net Income | -6.9 | -14.62 | -44.21 | -15.43 | -14.36 | -17.03 | Upgrade
|
| Net Income to Common | -6.9 | -14.62 | -44.21 | -15.43 | -14.36 | -17.03 | Upgrade
|
| Shares Outstanding (Basic) | 177 | 173 | 171 | 169 | 168 | 167 | Upgrade
|
| Shares Outstanding (Diluted) | 177 | 173 | 171 | 169 | 168 | 167 | Upgrade
|
| Shares Change (YoY) | 3.19% | 1.15% | 1.51% | 0.78% | 0.14% | 0.90% | Upgrade
|
| EPS (Basic) | -0.04 | -0.08 | -0.26 | -0.09 | -0.09 | -0.10 | Upgrade
|
| EPS (Diluted) | -0.04 | -0.08 | -0.26 | -0.09 | -0.09 | -0.10 | Upgrade
|
| Free Cash Flow | - | -24.12 | 12.05 | 20.71 | -8.01 | -9.7 | Upgrade
|
| Free Cash Flow Per Share | - | -0.14 | 0.07 | 0.12 | -0.05 | -0.06 | Upgrade
|
| Gross Margin | 8.89% | 9.55% | 9.24% | 6.52% | 8.95% | 7.58% | Upgrade
|
| Operating Margin | 1.10% | 0.99% | 0.44% | 1.54% | 2.68% | 0.33% | Upgrade
|
| Profit Margin | -1.21% | -3.88% | -11.95% | -1.99% | -2.14% | -3.44% | Upgrade
|
| Free Cash Flow Margin | - | -6.40% | 3.26% | 2.68% | -1.19% | -1.96% | Upgrade
|
| EBITDA | 16.84 | 15.16 | 10.76 | 21.44 | 24.44 | 7.67 | Upgrade
|
| EBITDA Margin | 2.96% | 4.02% | 2.91% | 2.77% | 3.64% | 1.55% | Upgrade
|
| D&A For EBITDA | 10.56 | 11.43 | 9.14 | 9.52 | 6.45 | 6.04 | Upgrade
|
| EBIT | 6.28 | 3.73 | 1.62 | 11.92 | 17.99 | 1.62 | Upgrade
|
| EBIT Margin | 1.10% | 0.99% | 0.44% | 1.54% | 2.68% | 0.33% | Upgrade
|
| Effective Tax Rate | - | - | - | - | 136.80% | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.